Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab (ROCKA Study)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ROCKA Study
- Sponsors AbbVie
- 07 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Feb 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
- 06 Feb 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.